SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000935836-22-000194
Filing Date
2022-02-15
Accepted
2022-02-15 14:43:34
Documents
1
Group Members
ANUPAM DALAL

Document Format Files

Seq Description Document Type Size
1 larimar13ga1.htm SC 13G/A 36139
  Complete submission text file 0000935836-22-000194.txt   37957
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Subject) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88225 | Film No.: 22638642
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1301 SHOREWAY ROAD SUITE 350 BELMONT CA 94002
Business Address 1301 SHOREWAY ROAD SUITE 350 BELMONT CA 94002 650-529-8000
ACUTA CAPITAL PARTNERS, LLC (Filed by) CIK: 0001582844 (see all company filings)

IRS No.: 452817402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A